1. Introduction {#sec1}
===============

Acute eosinophilic pneumonia (AEP) is a rare disorder marked by hypoxemia, pulmonary infiltrates and pulmonary eosinophilia [@bib1; @bib2]. AEP occurs secondary to medications or hypersensitivity reactions to an inhaled antigen (such as tobacco smoke) [@bib3; @bib4; @bib5; @bib6; @bib7; @bib8]. Hematopoietic stem transplant and autoimmune diseases are associated with eosinophilic lung disease and also need to be distinguished from idiopathic AEP [@bib1; @bib9].

Current data on idiopathic AEP is limited. Diagnostic criteria vary but typically include an acute febrile illness, hypoxemic respiratory failure, diffuse pulmonary infiltrates on imaging, and pulmonary eosinophilia with exclusion of known causes of pulmonary eosinophilia [@bib2]. Reported case series demonstrate variations in duration of illness, definition of fever (or documentation of anti-pyretic use), definition of pulmonary eosinophilia, documentation of hypoxia and exclusion of atopy, allergic rhinitis and asthma [@bib2; @bib8; @bib10; @bib11; @bib12]. The extent to which known causes of pulmonary eosinophilia were excluded also varies.

We performed a single-center retrospective case review and literature review to summarize available data. Our objective was to focus on idiopathic AEP (by carefully excluding known causes of pulmonary eosinophilia) and examining disease characteristics in our series and prior reports.

2. Methods {#sec2}
==========

This protocol was approved by the Institutional Review Board (\#10-006298). We searched the computerized medical records from January 1, 1997 to October 15, 2010 of patients consenting to research for the term "eosinophilic pneumonia". Those patients were screened for presence of pulmonary eosinophilia (demonstrated eosinophils on lung biopsy or BAL with \>25% eosinophils) [@bib2; @bib10]. Patients met criteria for inclusion if aged 18 years or older with an acute febrile illness (\<45 days in duration), hypoxemia or desaturation (nadir oxygen saturation (SpO~2~) \< 90% or PaO~2~ \<60 mm Hg), diffuse pulmonary infiltrates on chest imaging (chest radiograph or chest computed tomography), and pulmonary eosinophilia (as defined above). Patients were excluded with asthma or other known causes of pulmonary eosinophilia. Patients meeting these criteria were categorized as "definite" idiopathic AEP. Patients with a maximal temperature of 37.2 ^○^C or above (but less than 38.0 ^○^C) without subjective fevers or illness duration greater than 30 days were characterized as "probable" idiopathic AEP. Charts were reviewed for demographics, laboratory and imaging findings, and clinical course.

3. Results {#sec3}
==========

195 patients with suspected "eosinophilic pneumonia" demonstrated pulmonary eosinophilia (as defined above). Of these 195, 12 patients were included and 183 were excluded for various reasons (see [Fig. 1](#fig1){ref-type="fig"}). Thirteen patients were excluded due to relapse of symptoms on steroid taper and 2 patients were excluded due to lack of diffuse infiltrates on chest imaging. Five patients had all characteristics consistent with the diagnosis of idiopathic AEP. Three patients were categorized as "probable" idiopathic AEP due to exceeding expected 30-day symptom duration (37 and 38 days) and/or maximal temperature less than 38 ^○^C and are included in analysis. Four patients were defined as "possible" idiopathic AEP given history of polymyalgia rheumatica, eczema or allergic rhinitis and are described but not included in analysis. Clinical features of included patients are summarized in [Table 1](#tbl1){ref-type="table"} and [Table 2](#tbl2){ref-type="table"}.

4. Discussion {#sec4}
=============

4.1. Presenting symptoms {#sec4.1}
------------------------

While idiopathic AEP is by definition an acute illness, the symptom duration has been variably defined as less than 7 [@bib11] or less than 30 days [@bib2] without significant differences in the clinical manifestations. We examined all cases of possible idiopathic AEP of less than 45 days duration and describe two cases with symptoms slightly longer than 30 days as "probable" AEP. Although it can be argued that a longer duration of symptoms may lead to confusion with chronic eosinophilic pneumonia, the average duration of symptoms in chronic eosinophilic pneumonia is significantly longer (19.7 weeks) and the disease characteristics are distinct [@bib13].

Likewise the definition of "febrile illness" varies in the reported literature including temperatures as low as 37.2 °C [@bib6; @bib12]. We used subjective fevers or a temperature of 38 °C. We have included one patient without fever who was using anti-pyretic agents. Little attention has been made to the presence or absence of anti-pyretic agents or cooling device use in prior reported cases. Furthermore, patients with sepsis may have an abnormally low temperature in lieu of fever. It is unknown if this is also true of AEP as such patients have by definition been excluded from AEP criteria. With this in mind clinicians should consider AEP in patients in the absence of fever if other features are compatible.

Hypoxemia has been typically described as a PaO~2~ less than 60 mm Hg or a pulse oximetry saturation of less than 90% on room air [@bib2]. However, one recent case series did not use hypoxia/hypoxemia as an inclusion criteria for potential cases of idiopathic AEP [@bib12]. In reviewing the literature, little attention has been paid to desaturation with activity. Some of our patients did not have hypoxia at rest but had hypoxia with minimal exertion. Desaturation with activity should be considered as a criterion for AEP. In patients without hypoxia but with other classic features AEP should be considered.

Pulmonary eosinophilia is perhaps the most straightforward criteria. Our case series included cases diagnosed by lung biopsy or by BAL consistent with prior reports [@bib2; @bib10]. Interestingly one prior report described a patient with a low eosinophil count on bronchial wash with a subsequent elevated BAL eosinophil count [@bib14]. This emphasizes the need for a formal BAL in order to assure accurate diagnostics.

Finally, Philit et al. described "bilateral diffuse infiltrates on chest radiography" as a criterion for AEP [@bib2]. Others have included "diffuse pulmonary infiltrates" without stipulating type of imaging or bilateral nature [@bib12]. We have included diffuse pulmonary infiltrates by either chest CT or CXR in our inclusion criteria and believe clinicians should use similar criteria in considering this diagnosis.

4.2. Exclusion of "causes of pulmonary eosinophilia" {#sec4.2}
----------------------------------------------------

Perhaps the most controversial decision is whether to include or exclude patients with atopy or asthma from the case series. Some authors have proposed that patients with atopy have a predisposition to AEP [@bib14] while others have excluded such patients as having an alternate explanation of pulmonary eosinophilia.^4^ We have highlighted in [Table 3](#tbl3){ref-type="table"} the variability in the literature regarding atopy inclusion. We did not include asthmatic patients and have deemed those with allergic rhinitis or atopy as "possible" cases of AEP. Given the controversy, clinicians should be aware that atopy and asthma are not universally considered exclusive of AEP.

4.3. Disease severity {#sec4.3}
---------------------

Our case series demonstrates variation in disease severity with only two patients requiring intubation for respiratory failure. Approximately 16% of all reported patients required intubation ([Table 3](#tbl3){ref-type="table"}). We do not report any deaths, shock, or extra-corporeal membrane oxygenation use but such reports exist in the literature [@bib8; @bib14; @bib15; @bib16; @bib17; @bib18; @bib19]. Conversely many case series include patients with spontaneous resolution without steroid use [@bib2; @bib6; @bib20; @bib21]. All of our patients received some duration of corticosteroid therapy.

4.4. Treatment {#sec4.4}
--------------

Treatment in our case series ranged from 35 to 285 days of corticosteroid taper with a median duration of 60 days. The literature also contains a spectrum of treatment regimens from 125 mg methylprednisolone every six hours followed by prolonged steroid taper to no treatment at all. Although not demonstrated in our current case series, a recent retrospective report by Rhee et al. seems to support a two-week duration of corticosteroid treatment [@bib12].

4.5. Relapses {#sec4.5}
-------------

It is believed that relapse is not consistent with a diagnosis of AEP [@bib1; @bib20] and therefore we excluded 13 patients from our case series with relapse of symptoms. It should be noted however that relapses have been reported [@bib12; @bib22] as has positive cigarette smoke provocation test in AEP patients [@bib6; @bib7]. Clinicians should be aware of this potential when counseling their patients.

4.6. Sex and age trends {#sec4.6}
-----------------------

Approximately 80% of reported patients are males ([Table 3](#tbl3){ref-type="table"}). It is unclear whether this reflects smoking or occupational differences by gender (for example, two case series are of military personnel [@bib8; @bib12]) or an actual tendency. Likewise young age has been previously reported, however, the oldest patient in our case series is 79-years old. This suggests the diagnosis should be considered regardless of age in patients with pulmonary infiltrates of non-infectious etiology.

4.7. Smoking history {#sec4.7}
--------------------

Interestingly the patients in our series did not have a new or increased smoking history contrary to prior published associations [@bib2; @bib6; @bib7; @bib8]. Eighty-three percent of all reported patients are current smokers ([Table 3](#tbl3){ref-type="table"}). It is difficult to differentiate between new-onset smokers or individuals with alterations in smoking habits due to reporting styles and differing cutoffs in the articles presented. Only one of our eight patients had recently altered smoking habits (patient 6). So while smoking is a known association, individuals who lack this history should not be discounted.

5. Conclusions {#sec5}
==============

Idiopathic AEP is a truly rare condition comprising approximately 4% of cases of pulmonary eosinophilia at our institution. Inclusion criteria vary but consideration should be made for patients with pulmonary eosinophilia by BAL or biopsy and diffuse pulmonary infiltrates. Other criteria include approximately one month of symptoms, desaturation at rest or with exercise, and subjective or objective fevers. Not all reported cases appear to meet all criteria and disease severity can range from self-resolving to fatal. Idiopathic AEP should remain in the differential regardless of age, sex, or smoking association although these remain diagnostic clues.
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###### 

Description of cases at our institution.

  Patient                                Age at diagnosis   Sex   Maximal temperature (celsius)   Fevers or chills   Nadir SpO~2~ (%)   Symptom duration (days)   Bilateral infiltrates modality   BAL eosinophils (%)   Eosinophils present on biopsy
  -------------------------------------- ------------------ ----- ------------------------------- ------------------ ------------------ ------------------------- -------------------------------- --------------------- -------------------------------
  1                                      45                 M     38.6                            Yes                79                 7                         CXR                              53                    Yes
  2                                      32                 F     37.6                            Yes                68                 15                        CT                               34                    Not performed
  3                                      61                 M     39.7                            Yes                83                 4                         CXR                              9                     Yes
  4                                      74                 M     37.8                            Yes                85                 21                        CXR                              42                    Yes
  5                                      76                 M     37.4                            Yes                86                 21                        CXR                              37                    No
  6                                      19                 F     39.0                            Yes                61                 38                        CXR                              28                    Not performed
  7                                      79                 F     37.5                            No                 82                 37                        CXR                              20                    Yes
  8                                      22                 M     37.2                            No                 83                 30                        CXR                              87                    Yes
  9[a](#tbl1fna){ref-type="table-fn"}    73                 F     38.0                            No                 81                 7                         CT                               6                     Yes
  10[b](#tbl1fnb){ref-type="table-fn"}   72                 M     37.0                            Yes                89                 14                        CXR                              80                    Not performed
  11[c](#tbl1fnc){ref-type="table-fn"}   57                 M     37.3                            Yes                83                 35                        CT                               Not performed         Yes
  12[d](#tbl1fnd){ref-type="table-fn"}   22                 M     38.7                            Yes                88                 2                         CXR                              60                    Not performed

Patients who meet all criteria for idiopathic acute eosinophilic pneumonia (cases 1--5), probable idiopathic acute eosinophilic pneumonia (cases 6--8), or possible eosinophilic pneumonia despite history of atopic disease (cases 9--12). CXR: chest radiograph. CT: Computed tomography.

Patient with history of polymyalgia rheumatica.

Patient with history of polymyalgia rheumatica.

Patient with history of eczema, rheumatoid arthritis.

Patient with history of allergic rhinitis (required intubation).

###### 

Summary of clinical features of definite and probable idiopathic AEP cases at our institution.

  ------------------------------------------------ -----------------------
  Age                                              53 years old (19--79)
  Male                                             63%
  Duration of symptoms                             21 days (4--38)
  Maximum temperature                              37.7 °C (37.2--39.7)
  Nadir SpO~2~                                     83% (61--86)
  White blood cell count on admission (×10^9^/L)   13.2 (7.3--27.8)
  Eosinophil count on admission (×10^9^/L)         0.34 (0.01--10.56)
  BAL eosinophils                                  36% (9--87)
  Duration of hospitalization                      7 days (1--12)
  Intubation                                       25% (1--3 days)
  Duration of steroids therapy                     60 days (35--285)
  ------------------------------------------------ -----------------------

All numbers above are median (range) unless otherwise noted.

###### 

Summary of available IAEP case-series.

                                      Number of patients   Male                                    Female   Age           Current smokers   Number requiring intubation   BAL eosinophils %                  Patients with atopic disease/asthma included
  ----------------------------------- -------------------- --------------------------------------- -------- ------------- ----------------- ----------------------------- ---------------------------------- ----------------------------------------------
  Allen et al., 1989 [@bib23]         4                    3                                       1        34 (Mean)     Unclear           2/4                           42 (Mean)                          No asthma
  Umeki et al., 1992 [@bib24]         5                    4                                       1        37.7 (Mean)   3/5               Unclear                       20.3 (Mean for 3 patients)         Yes
  Ogawa et al., 1993 [@bib21]         5                    5                                       0        28.2 (Mean)   3/5               Unclear                       42.4 (Mean)                        Yes
  Hayakawa et al., 1994 [@bib20]      13                   9                                       4        37.2 (Mean)   Unclear           Unclear                       40.3 (Mean)                        Yes
  Cheon et al., 1996 [@bib25]         6                    4                                       2        29 (Mean)     1/5               Unclear                       Unclear                            No
  Pope-Harman et al., 1996 [@bib11]   15                   9                                       6        28.9 (Mean)   6/15              8/15                          36.9 (Mean)                        Unclear
  Tazelaar et al., 1997 [@bib10]      9                    4                                       5        53 (mean)     3/9               Unclear                       1 (Only 1 patient underwent BAL)   Yes
  Shiota et al., 2000 [@bib22]        2                    2                                       0        23 (Mean)     2/2               0/2                           47 (Mean)                          No
  Philit et al., 2002 [@bib2]         22                   13                                      9        29 (Mean)     8/22              8/22                          54.4 (mean)                        Yes
  Shorr et al., 2004 [@bib8]          18                   16[a](#tbl3fna){ref-type="table-fn"}    2        22 (Median)   18/18             12/18                         40.5 (Median)                      Unclear
  Miyazaki et al., 2007 [@bib26]      17                   11                                      6        19 (Median)   16/17             0/17                          65 (Median)                        Yes
  Daimon et al., 2008 [@bib27]        29                   14                                      15       26 (Mean)     Unclear           Unclear                       Unclear                            No
  Uchiyama et al., 2008 [@bib6]       33                   23                                      10       19.3 (Mean)   32/33             Unclear                       52.8 (Mean)                        Yes
  Rhee et al., 2013 [@bib12]          137                  137[a](#tbl3fna){ref-type="table-fn"}   0        20 (Median)   135/137           3/137                         40 (Median)                        Yes
  Our study                           8                    5                                       3        53 (Median)   2/8               2/8                           36 (Median)                        No
  Total                               323                  259                                     64       n/a           229/276           35/223                        Range 1--54.4%                     At least 8 studies

Military personnel study.
